Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Retrospective cohort analysis identifying prognostic factors and comparing outcomes across therapies in NPM1-mutated AML, with clear survival endpoints but limited by single-center design and observational methodology.
International Journal of Innovative Science and Research Technology
This is a narrative review summarizing biological mechanisms and therapeutic concepts without reporting original experimental data, clinical trials, or comparative efficacy evidence.
A single fatal case report proposing a mechanistic link between excessive nitrous oxide use, vitamin B12 deficiency, hyperhomocysteinemia, and pulmonary thromboembolism; raises a question rather than establishing causation.
Sound preclinical study with patient-derived models and in vivo validation showing XPO1 inhibition activates TP53 and reduces tumor burden, but lacks clinical trial data and human efficacy evidence.
This is a narrative review article evaluating druggability of retinoid-binding proteins based on structural and biochemical evidence, raising questions about therapeutic potential rather than reporting clinical trial results or definitive efficacy data.